Dong-A ST (170900 KS/Buy)Pipeline Progress Needed
We lower our target price for Dong-A ST to W50,000 (vs. the previous adjusted target price of W64,854, which reflects the share count change...
92 Views
Dong-A ST (170900 KS/Buy)Top-Line Growth Continues, but Margin Improvement Remains Limited
Imuldosa (Stelara biosimilar), previously treated as a pipeline asset and valued at W111.1bn, has now been incorporated into operating value...
117 Views